Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic testing in the acute setting: a round table discussion.

Journal of medical ethics - 1 Aug 2020

McDermott John Henry

Abstract excerpt

Genetic testing has historically been performed in the context of chronic disease and cancer diagnostics. The timelines for these tests are typically measured in days or weeks, rather than in minutes. As such, the concept that genetic information might be generated and then used to alter management in the acute setting has, thus far, not been feasible. However, recent advances in genetic technologies have the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminoglycosides
Share to Anti-Bacterial Agents
Share to Deafness

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Hearing Loss

Share to Hearing Tests

Share to Infant, Newborn

Share to Pharmacogenetics

Source

Open in PubMed Open full text

Identifiers

PMID: 32651253
DOI: 10.1136/medethics-2019-106043
PMCID: PMC7418589

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic testing in the acute setting: a round table discussion.PMID 32651253Read ↗

Rapid Point-of-Care Genotyping to Avoid Aminoglycoside-Induced Ototoxicity in Neonatal Intensive Care.Semantic proximity Read ↗

Non-invasive Prenatal MT-RNR1 Pharmacogenetic Testing for the Prevention of Aminoglycoside-Induced Profound Hearing LossSemantic proximity Read ↗

Using a bedside test to detect genetic susceptibility to aminoglycoside-induced hearing loss: Has the future arrived?Semantic proximity Read ↗

Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.Semantic proximity Read ↗

The future role of genetic screening to detect newborns at risk of childhood-onset hearing loss.Semantic proximity Read ↗

Gentamicin, genetic variation and deafness in preterm children.Semantic proximity Read ↗

Pharmacogenomic testing to prevent aminoglycoside-induced hearing loss in cystic fibrosis patients: potential impact on clinical, patient, and economic outcomes.Semantic proximity Read ↗

Genetic mutations associated with susceptibility to perioperative complications in a longitudinal biorepository with integrated genomic and electronic health records.Semantic proximity Read ↗

Clinical Pharmacogenomic MT-RNR1 Screening for Aminoglycoside-Induced Ototoxicity and the Post-Test Counseling Conundrum.Semantic proximity Read ↗

Challenges of implementing pharmacogenetics in the critical care environment.Semantic proximity Read ↗

Utility of genetic testing for the detection of late-onset hearing loss in neonates.Semantic proximity Read ↗

Genetic testing: costs and access to intensive care unit care.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.